Sustained ophthalmic delivery of moxifloxacin hydrochloride from an pH triggered in situ gelling system

Research Journal of Pharmacy and Technology

Volumn 5, Issue 12, 2012, Pages 1538-1542

  Gupta, S K ^a   Singhvi, I J ^a  

^a Pacific College of Pharmacy   (India)

Author keywords

Carbopol; In situ gelling; Moxifloxacin Hcl. sustained; Ophthalmic delivery systems

Indexed keywords

CARBOMER; HYDROXYPROPYLMETHYLCELLULOSE; MOXIFLOXACIN;

ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; DRUG STABILITY; FLOW KINETICS; GELATION; IN VITRO STUDY; LACRIMAL FLUID; PH; PROCESS OPTIMIZATION; SUSTAINED DRUG RELEASE; VISCOSITY;

EID: 84871549009     PISSN: 0974360X     EISSN: 09743618     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Drlica K, Zhao X. "DNA gyrase, topoisomerase IV, and the 4-quinolones". Microbiol Mol Biol Rev. 1 September 1997, 61 (3): 377-92.
2. Higuchi WI. The analysis of data on the medicament release from ointments. J Pharm Sci. 1962; 51:802-804.
3. McDonald MB, Protzko EE, Brunner LS, Morris TW, Haas W, Paterno MR, Comstock TL, Usner DW. Efficacy and safety of besifloxacin ophthalmic suspension 0.6% compared with moxifloxacin ophthalmic solution 0.5% for treating bacterial conjunctivitis. Optometry. 2009; 80:296-297.
4. Mundada AS, Shrikhande BK. Formulation and evaluation of ciprofloxacin hydrochloride soluble ocular drug insert. Curr Eye Res. 2008; 33:469-475.
5. Sieg JW, Robinson JR. Vehicle effects on ocular drug bioavailability. I: Evaluation of fluorometholone. J Pharm Sci. 1975;64:931-936
6. Nanjawade BK, Manvi FV, Manjappa AS. In situ-forming hydrogels for sustained ophthalmic drug delivery. J Contr Rel. 2007; 122:119-134.
7. Ganguly S, Dash AK. A novel in situ gel for sustained drug delivery and targeting. Int J Pharm. 2004; 276:83-92.
8. Bourlais CL, Needham T, Leverge R. Ophthalmic drug delivery systems. Prog Retin Eye Res 1998; 17:33-8.
9. Nanjawade BK, Manvi FV, Manjappa AS. In situ forming hydrogels for sustained ophthalmic drug delivery. J Control Release 2007; 122:119-34.
10. Miller SC, Donovan MD. Effect of Poloxamer 407 gel on the miotic activity of pilocarpine nitrate in rabbits. Int J Pharm. 1982; 12:147-152.
11. Gurny R, Boye T, Ibrahim H. Ocular therapy with nanoparticulate systems for controlled drug delivery. J Contr Rel. 1985; 2:353-361.
12. Rozier A, Mazuel C, Grove J, Plazonnet B. Gelrite®: a novel, ion-activated, in situ-gelling polymer for ophthalmic vehicles effect on bioavailability of timolol. Int J Pharm. 1989; 57:163-168.
13. Lin HR, Sung KC. Carbopol/pluronic phase change solutions for ophthalmic drug delivery. J Contr Rel. 2000; 69:379-388.
14. Hui HW, Robinson JR. Ocular delivery of progesterone using a bioadhesive polymer. Int J Pharm. 1985; 26:203-213.
15. Sanzgiri YD, Maschi S, Crescenzi V, Calligaro L, Topp EM, Stella VJ. Gellan-based systems for ophthalmic sustained delivery of methyl prednisolone. J Contr Rel. 1993; 26:195-201.
16. Meseguer G, Gurny R, Buri P, Rozier A, Plazonnet B. Gamma scintigraphic study of precorneal drainage and assessment of miotic response in rabbits of various ophthalmic formulations containing pilocarpine. Int J Pharm. 1993; 95:229-234.
17. Carlfors J, Edsman K, Petersson R, Jornving K. Rheological evaluation of Gelrite in situ gels for ophthalmic use. Eur J Pharm Sci. 1998; 6:113-119.
18. Cao YX, Zhang C, Shen WB, Cheng ZH, Yu LL, Ping Q. Poly(N-isopropylacrylamide)-chitosan as thermosensitive in situ gel-forming system for ocular drug delivery. J Contr Rel. 2007; 120:186-194.
19. Miyazaki S, Suzuki S, Kawasaki N, Endo K, Takahashi A, Attwood D. In situ gelling xyloglucan formulations for sustained release ocular delivery of pilocarpine hydrochloride. Int J Pharm. 2001; 229:29-36.
20. Carlfors J, Edsman K. Rheological evaluation of Gelrite in situ gels for ophthalmic use. Eur J Pharm Sci 1998; 6:113-9.
21. Cappuccino JG, Sherman N. Microbiology-A Laboratory manual. 4th ed. Delhi: The Benjamin/Cummings Company; 1996, p. 272-3.
22. Sultana Y, Jain R, Rathod R, Asgar Ali, Aqil M. Advances in ophthalmic drug delivery systems-Part II. Pharmainfo. net. 2005, 3 (3).
23. Kumar S, Himmelstein KJ. Modification of in situ gelling behavior of carbopol solution by hydroxyl propyl methyl cellulose. J Pharm Sci 1995; 84:344-8.
24. Doshi, H.A., Bhalla, H.L. In vitro and In vivo release of ciprofloxacin from ophthalmic formulation, Indian drugs, 37(4), 2000.